Although the overall survival of HCC patients with low PAD2 expression did not show any significant difference compared to patients with high PAD2 expression, tumor size was revealed to be only one risk factor for the overall survival in enrolled patients (Table 2). This evidence concerns the gene PADI2 and hepatocellular carcinoma.